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SUMMARY
In a longitudinal study, suppose that the primary endpoint is the time
to a specific event. This response variable, however, may be censored by an
independent censoring variable or by the occurrence of one of several depen-
dent competing events. For each study subject, a set of baseline covariates
is collected. The question is how to construct a reliable prediction rule for
the future subject’s profile of all competing risks of interest at a specific time
point for risk-benefit decision makings. In this paper, we propose a two-
stage procedure to make inferences about such subject-specific profiles. For
the first step, we use a parametric model to obtain a univariate risk index
score system. We then estimate consistently the average competing risks
for subjects which have the same parametric index score via a nonparamet-
ric function estimation procedure. We illustrate this new proposal with the
data from a randomized clinical trial for evaluating the efficacy of a treat-
ment for prostate cancer. The primary endpoint for this study was the time
to prostate cancer death, but had two types of dependent competing events,
one from cardiovascular death and the other from death of other causes.
Keywords: Local likelihood function; Nonparametric function estimation;
Perturbation-resampling method; Risk index score.
1
Hosted by The Berkeley Electronic Press
1. INTRODUCTION
Consider a longitudinal clinical study whose primary endpoint is the time
to a specific clinical event. However, this event time is possibly censored by
an independent censoring variable or by the occurrence of one of several
dependent competing events. For example, in a randomized clinical trial to
evaluate the efficacy of estrogen diethylstilbestrol (DES) for treating stage 3
or 4 prostate cancer, 242 patients were randomly assigned to two high dose
groups (≥ 1 mg/day) and 241 subjects were assigned to two low dose groups
(≤ 0.2 mg/day) (Byar and Green, 1980; Cheng et al., 1998). The primary
endpoint for the study is the time to prostate cancer death. At the end of the
study, there were 48, 78 and 34 deaths due to prostate cancer, cardiovascular
diseases and other causes in the high dose groups. For the low dose groups,
the corresponding numbers of deaths are 77, 61 and 46, respectively. With
respect to the overall survival, the high dose groups appeared to be superior
to the low dose groups. Furthermore, the treatment with high doses of DES
reduced the prostate cancer death. However, there was a serious concern
about its potential fatal cardiovascular-related toxicity.
To quantify the “pure” treatment effect for prostate cancer in the presence
of possibly dependent competing risks is a rather challenging task, if not
impossible (Tsiatis, 1975). The risk-benefit decision makings on the proper
usage of DES should depend on the entire profile of all competing risks,
not solely on the prostate cancer mortality. Moreover, since the choice of
balancing the risk and benefit is rather subject-specific, it is important to
know how to utilize the future patient’s “baseline” characteristics to predict
such an individual-level competing risk profile.
A classical method of handling dependent competing risk problem is to
model the so-called cause-specific hazard function for the primary endpoint
via the Cox proportional hazards model (Cox, 1972). However, it is not
clear how to utilize this technique to make survival predictions (Kalbfleisch
and Prentice, 1980; Pepe and Mori, 1993). A useful alternative to deal with
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competing risks is to consider the cumulative incidence functions (Benichou
and Gail, 1990; Gaynor et al., 1993; Gelman et al., 1990; Korn and Dorey,
1992; Goldhirsch et al., 1994). Recently Cheng et al. (1998) and Fine and
Gray (1999) modeled the cumulative incidence function with the subject’s
covariates, for example, via a Cox-type model. Further novel procedures
along this line have been studied, for example, by Fine (2001), Klein and
Andersen (2005), Klein (2006) and Scheike et al. (2008). Another fruitful
class of parametric or semi-parametric methods is to consider latent failure
time modeling (Kalbfleisch and Prentice, 2002; Lawless, 2003; Andersen et
al., 2002; Li et al., 2007) to analyze the competing risk data. The validity
of predicting the competing risk profiles based on a parametric or semi-
parametric model is heavily dependent on the adequacy of the fitted model.
In this paper, we are interested in constructing subject-level predictions
of all dependent competing risks of interest at a specific time point, or a set
of time points. When, for each subject, more than one baseline covariate
is involved, a purely nonparametric function estimation procedure for the
above event rates may not perform well even with relatively large samples.
Here, we consider the case that there is a primary event of interest and
construct a two-stage procedure. For the first step, we use a parametric or
semi-parametric model to create a univariate risk index score. We then use
a nonparametric function estimation method to make joint inferences about
the average competing risks for subjects with the same index score. The new
proposal is illustrated with the data from the above DES study. Note that a
similar approach has been taken along this line for predicting the individual-
level single event rate without the presence of competing risks by Cai et al.
(2008).
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2. CONSISTENT ESTIMATION FOR MEAN COMPETING
RISKS OF SUBJECTS WITH THE SAME PARAMETRIC
RISK SCORE
Suppose that there are K distinct types of possibly dependent competing
events. For a random subject in the study, let T˜ be the study time period
from the study entry to the first time point at which one out of these K events
occurs. Let  be a random variable whose possible values are {1, · · · , K}. If
 = k, Type k event is observed at T˜ . Also, let U be the subject’s “baseline”
covariate vector. Furthermore, suppose that we are interested in the K
conditional event rates at a specific time point t0, that is,
pik(U) = pr(T˜ ≤ t0,  = k | U), k = 1, · · · , K. (2.1)
In practice, T˜ is often censored by an independent continuous variable C with
an unknown survival distribution G(·). Assume that C is independent of T˜
and U. Let T = min(T˜ , C) and ∆ = I(T˜ = T ), where I(·) is the indicator
function. Also, let {(T˜i, Ci, i, Ui), i = 1, · · · , n} be n independent copies of
(T˜ , C, , U). The problem is how to make inference about (2.1) based on the
incomplete event time observations {(Ti,∆ii, Ui), i = 1, · · · , n}. Unfortu-
nately, if the dimension of U is greater than one, any existing nonparametric
regression estimator for (2.1) may not perform well even when the sample
size n is large and the event rates are not extremely low or high. Instead of
estimating such fine subject-level event rates (2.1), a feasible, practical alter-
native is to construct a univariate parametric risk index system based on U
and group the study subjects with respect to this scoring system. Then using
a univariate nonparametric function estimation procedure, one may estimate
consistently these K average competing event rates for each stratum whose
subjects have the same index score.
To construct a univariate scoring system, we consider the case that there
is a primary event of interest for the study, say, the event corresponding to
 = 1. Let X, a p× 1 vector, be a function of U and the first component of
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X is one. Let Xi be the counterpart of X from Ui, i = 1, · · · , n. Consider a
parametric working model for the primary event rate:
pi1(U) = g(β
′X), (2.2)
where g is a known strictly increasing, smooth function, for example, the
anti-logit function, and β is a p × 1 vector of unknown parameters. With-
out censoring, one may use the maximum likelihood estimator or a simple
estimating function such as
n−1
n∑
i=1
Xi{I(Ti ≤ t0,  = 1)− g(β′Xi)} (2.3)
to estimate β.
In the presence of independent right censoring, one may modify (2.3) by
adjusting censoring. One possible modification is
R(β) = n−1
n∑
i=1
wi
Gˆ(Ti ∧ t0)
Xi{I(Ti ≤ t0,  = 1)− g(β′Xi)}, (2.4),
where wi = I(Ti∧t0 ≤ Ci) = I(Ti ≤ t0)∆i+I(Ti ≥ t0) and Gˆ(·) is the Kaplan-
Meier estimator for G(·). This generalization has been studied, for example,
by Zheng et al. (2007) and Uno et al. (2008) for handling various problems
in survival analysis. Heuristically, for a large sample size n, conditional on T˜
and U, the expected value of wi/Gˆ(Ti∧t0) is approximately one. This implies
that for large n, R(β) ≈ (2.3). Therefore, asymptotically one would expect
that a root βˆ to R(β) = 0 is free of the study-specific censoring distribution
G(·). It is important to note that under rather mild conditions, βˆ converges
to a finite value β0 even when the model (2.2) is not correctly specified (Uno
et al., 2008). This stability property, coupled with the fact that β0 is free
of the study-specific censoring distribution, is essential for developing our
inference procedures. Note that if the model (2.2) is correctly specified, the
estimate g(βˆ′X) would be a consistent estimator for (2.1).
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Now, consider a future subject from the same study population, whose U
and X are U0 and X0 with potential, but unobservable (T˜ , )′ = (T˜ 0, 0)′. Let
βˆ′X0 = v, a given constant. We are interested in estimating the following
(K − 1) average event rates at time t0 :
pr(T˜ 0 ≤ t0, 0 = k | βˆ′X0 = v), k = 1, · · · , K − 1, (2.5)
where the probability is with respect to the future observation (U0, T˜ 0, 0)
as well as the observed data {(Ti,∆ii, Ui), i = 1, · · · , n}, from which βˆ is
estimated. Note that the probabilities in (2.5) depend on the sample size n
and are convergent to the following conditional probabilities
ηk(v) = pr(T˜
0 ≤ t0, 0 = k | β′0X0 = v), k = 1, · · · , K − 1, (2.6)
as n → ∞. Also note that (2.6) is the set of the multinomial cell prob-
abilities for future subjects whose limiting risk score is v. For the non-
censored case, let us consider a nonparametric estimation procedure for
η(v) = {η1(v), · · · , ηK−1(v)}′ via a localized multinomial likelihood func-
tion. Specifically, let Yik = I(Ti ≤ t0, i = k) for k = 1, . . . , K − 1, and
βˆ′Xi = Vˆi. Then, a kernelized log-likelihood function for η(v), expressed with
the unknown parameter vector p = (p1, · · · , pK−1)′ is
n∑
i=1
Kh(Vˆi − v)
K−1∑
k=1
log
{
pYikk (1−
K−1∑
k=1
pk)
1−∑K−1k=1 Yik
}
, (2.7)
where pk ≥ 0,
∑K−1
k=1 pk ≤ 1, Kh(s) = K(s/h)/h for a symmetric standard
kernel function K(·) with a finite support and h is the smooth parameter. In
the presence of censoring, we add a weight function wi/Gˆ(Ti ∧ t0) in front of
Kh(·) in (2.7). The resulting log-likelihood is
n∑
i=1
wi
Gˆ(Ti ∧ t0)
Kh(Vˆi − v)
K−1∑
k=1
log
{
pYikk (1−
K−1∑
k=1
pk)
1−∑K−1k=1 Yik
}
. (2.8)
An estimator for η(v) can be obtained by maximizing (2.8) with respect to
p’s with the above constraints.
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The performance of this nonparametric local estimator may be improved
by replacing pk of each summand in (2.8) by
exp{ak + bk(Vˆi − v)}
1 +
∑K−1
i=1 exp{ak + bk(Vˆi − v)}
,
where a = (a1, · · · , aK−1)′ and b = (b1, · · · , bK−1)′ are unknown vectors of
parameters. Here, the rational is to use a linear function ak + bk(V − v) to
approximate log{ηk(V )/ηK(V )} in a small neighborhood of v. The resulting
log-likelihood function is
`(a, b; v) =
n∑
i=1
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)
K−1∑
k=1
(
Yik{ak + bk(Vˆi − v)}
− log[1 +
K−1∑
k=1
exp{ak + bk(Vˆi − v)}]
)
. (2.9)
Let aˆ and bˆ be the maximizers for `(a, b; v) with respect to a and b. Also, let
ηˆk(v) be
exp(aˆk)/[1 +
K−1∑
k=1
exp(aˆk)], k = 1, · · · , K − 1. (2.10)
In Appendix A, we show that when h = O(n−ν), 1/5 < ν < 1/2, ηˆk(v) is con-
sistent estimator for ηk(v), k = 1, · · · , K−1. Moreover, the joint distribution
of
{(nh)1/2[f{ηˆk(v)} − f{ηk(v)}], k = 1, · · · , K − 1} (3.1)
can be approximated by a multivariate normal with mean 0 and covariance
matrix Σ(v), where f(·) : [0, 1] → [−∞,∞] is a given smooth, strictly in-
creasing function. In this paper, we let f(·) be the logit function.
3. CONSTRUCTING POINTWISE AND SIMULTANEOUS
CONFIDENCE INTERVALS FOR ηk(·) OVER THE RISK
SCORE
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To estimate the covariance matrix Σ(v) associated with (3.1), we utilize a
perturbation-resampling procedure which is similar to a wild bootstrapping
method (Mammen, 1993) and has been successfully applied to many inter-
esting inference problems, especially in survival analysis (Gilbert et al, 2004;
Tian et al. 2005). Specifically, let {Bi, i = 1, · · · , n} be a random sample
from the unit exponential. Let a∗ = {a∗1, · · · , a∗K−1}′ be the minimizer of
`∗(a, b; v), a perturbed version of (2.9), where
`∗(a, b; v) =
n∑
i=1
Bi
wiKh(V
∗
i − v)
G∗(Ti ∧ t0)
( K−1∑
k=1
Yik{ak + bk(V ∗i − v)}
− log[1 +
K−1∑
k=1
exp{ak + bk(V ∗i − v)}]
)
.
Here, G∗(·) and V ∗i are the perturbed counterparts of Gˆ(·) and Vˆi, respec-
tively, where
G∗(t) = exp
[
−
n∑
i=1
∫ t
0
Bid{I(Ti ≤ s,∆i = 0)}∑n
j=1 BjI(Tj ≥ s)
]
,
V ∗i = X
′
iβ
∗ and β∗ is the solution to the perturbed estimating equation of
(2.4)
n∑
i=1
Biwi
G∗(Ti ∧ t0)Xi{I(Ti ≤ t0,  = 1)− g(X
′
iβ)} = 0.
Furthermore, let the corresponding perturbed η∗k(v) be
exp(a∗k)/[1 +
K−1∑
k=1
exp(a∗k)], k = 1, · · · , K − 1.
It follows from similar arguments given in Cai et al. (2008) that conditional
on the data, the limiting distribution of
{(nh)1/2[f{η∗k(v)} − f{ηˆk(v)}], k = 1, · · · , K − 1}
is the same as the unconditional distribution of (3.1). The covariance ma-
trix Σ(v) is identical to the limit of Σˆ(v), the conditional expected value
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of (nh)[f{η∗(v)} − f{ηˆ(v)}][f{η∗(v)} − f{ηˆ(v)}]′ (conditional on the data),
where f{η∗(v)} = (f{η∗1(v)}, · · · , f{η∗K−1(v)})′ and f{ηˆ(v)} = (f{ηˆ1(v)}, · · · ,
f{ηˆK−1(v)})′.
To obtain an approximation to Σˆ(v) for a given data set, we generate
a large number, M, of independent realizations from {Bi, i = 1, · · · , n}.
For each realization, we obtain a realization of f{η∗(v)}. With M such
independent realizations, one may use the standard sample covariance matrix
estimate Σ˜(v) or a robust version thereof to estimate Σ(v). This, coupled with
the normal approximation to the distribution of f{ηˆ(v)}, provides confidence
intervals for f{ηk(v)}. A two sided (1− α) confidence interval for ηk(v) is
f−1[f{ηˆk(v)} ± z(1−α/2)(nh)−1/2σ˜k(v)], (3.2)
where f(·) is the logit function, z(1−α/2) is the (1 − α/2) quantile of the
standard normal distribution and σ˜k(v) is the standard error estimate from
the kth diagonal element of Σ˜(v). Note that joint confidence regions for
{ηk(v), k = 1, · · · , K − 1} can also be obtained by considering a sup-type
statistic: supk=1,··· ,K−1|ηˆk(v) − ηk(v)| to choose the cutoff point for the con-
fidence intervals (3.2).
Note that since the convergence rate for ηˆ(v) is slower than square root n,
in theory, there is no need to consider the sampling variation from βˆ and Gˆ(·)
for constructing asymptotically valid confidence intervals. However, we find
via extensive empirical studies that utilization of such perturbed versions of
these statistics can substantially improve the finite sample performance of
the nonparametric function estimation.
To construct a (1−α) simultaneous confidence band for ηk(v) over a pre-
specified interval I of v, we cannot use use the conventional method based on
a sup-statistic, supv∈I σ˜−1k (v)|(nh)1/2{ηˆk(v)−ηk(v)}| due to the fact that as a
process in v, the limiting distribution of (nh)1/2{ηˆk(v)−ηk(v)} does not exist.
On the other hand, one may utilize the strong approximation argument given
in Bickel and Rosenblatt (1973) to show that the appropriately scaled sup
of a specific transformation of ηˆk(v) converges to a proper random variable
9
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in distribution. In practice, a (1 − α) simultaneous confidence band for
{ηk(v), v ∈ I} is
f−1[f{ηˆk(v)} ± cα(nh)−1/2σ˜k(v)], (3.3)
where cα is obtained via the following equation:
pr(supv∈I σ˜
−1
k (v)|(nh)1/2[f{η∗k(v)} − f{ηˆk(v)}]| < cα) = 1− α,
and {η∗k(v), v ∈ I} is obtained by the above perturbation-resampling method
with the same set of {Bi, i = 1, · · · , n}. The justification of adequacy of
this approximation is given in Appendix B. Note that unlike the pointwise
confidence interval estimation for ηk(v), it does not seem trivial to generalize
the above simultaneous confidence interval estimation for all k = 1, · · · , K−
1.
Like any typical nonparametric function estimation problem, it is im-
portant to know how to choose the smooth parameter h in practice. Here,
we propose a J−fold cross-validation method to choose an optimal h value.
To this end, we first randomly divide the entire data set D into J mutu-
ally exclusive, roughly equally sized subsets, say, D1, · · · , DJ . Let the set
of observations in D, but not in Dj, be denoted by D(−j), j = 1, · · · , J. We
construct the scoring system based on observations in D(−j) based on the es-
timate βˆ(−j). Next, for a fixed h value, let the corresponding nonparametric
estimator for ηk(v) be ηˆ(k,−j)(v). With these subject-specific risk estimates,
we compute the log-likelihood function with observations in Dj:
`j(h) = −
∑
l∈Dj
wl
Gˆ(Tl ∧ t0)
[
K∑
k=1
Ylk log{ηˆ(k,−j)(V(l,−j))}
]
, (3.4)
where ηˆ(K,−j)(v) = 1−
∑K−1
k=1 ηˆ(k,−j)(v) and Vˆ(l,−j) = βˆ
′
(−j)Xl, l ∈ Dj. Now, let
`cv(h) =
∑J
j=1 `j(h). We choose the maximizer hop of `cv(h) as an “optimal”
choice of the smooth parameter h.
It follows from the argument in Hardle et al. (1988), we expect that the
above hop is in the order of Op(n
−1/5). To ensure that the validity of the
10
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aforementioned large sample properties for ηˆk(v), one may choose a smooth
parameter h = hop × n−ξ where 0 < ξ < 3/10. In practice, we find that the
resulting nonparametric estimator performs well with ξ = 0.1.
4. EXAMPLE
We illustrate the new proposal with a subset of the data from the DES
trial discussed in the Introduction section. This data set consists of patient-
level observations from the high DES dose groups. There were 242 patients
in these groups with a median followup time of 63 months. Here, T˜ is the
time from randomization to one of K = 4 competing events, and  = 1, for
prostate cancer death; = 2, for cardiovascular related death; and = 3, for
other causes of death; = 4, for surviving beyond t0. At the end of the study,
there were 48, 78 and 34 patients died due to prostate cancer, heart diseases
and other causes, respectively. The baseline covariate vector U includes Age
(AG), weight index (WT), performance rating (PF), history of cardiovascu-
lar disease (HX), serum hemoglobin (HG), size of primary lesion (SZ) and
Gleason score (SG). Since this data set was analyzed in the past using a
discretized coding system for the covariates due to an easy clinical interpre-
tation (Byar and Green, 1980; Cheng et al., 1998), we followed the same
system in our analysis. For convenience to readers, the coding for covariates
is summarized in Table 1.
First, we consider a case for predicting the subject-level relatively long
term competing risks. To this end, let t0 = 5 (years). Since the primary
endpoint of the study is the time to prostate cancer death, we fitted the
data with a working model (2.2) by letting X = (1, U)′ and g be the anti-
logit function. The point estimate βˆ for β via (2.4) is given in Table 2
(a). Although only WY, SZ and SG are statistically significant with this
working model, we used the entire covariate vector U to build the risk scoring
V = βˆ′X. In Figure 1(a), we present a smoothed density estimate of V, which
is a bimodal function. Most study subjects are clustered around V = −4.5
and −0.9.
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To estimate ηk(v), k = 1, 2, 3, we let the kernel Kh(·) for ηˆk(v) be the stan-
dard Epanechnikov function. The smoothing parameter h was chosen by min-
imizing `cv(h) defined in Section 3 with a 10-fold cross-validation procedure.
Moreover, to make the smooth parameter in the order of slightly larger than
n−0.2, we multiply the above optimal value by 10−0.1. This results in h = 0.97.
Lastly we let the 2nd and 98th percentiles of the empirical distribution of V
be the the boundary points of I. We then constructed pointwise and simul-
taneous confidence intervals for {ηk(v), v ∈ I} with M = 1000 realizations of
the random sample from the unit exponential for the perturbation-resampling
procedure. In Figure 1(b), for the prostate cancer 5-year mortality rate es-
timation, we present the point estimates {ηˆ1(v), v ∈ I} with the solid curve,
and the 0.95 pointwise intervals (enclosed by dotted curves) and simultane-
ous band (gray shaded zone). For example, the estimated average prostate
cancer mortality rate for patients with an index score of -4.5 was 0.012 with
a 95% simultaneous confidence interval of (0.0006,0.17) and a 95% point-
wise confidence interval of (0.002,0.05), while the estimated average prostate
cancer mortality rate for patients with an index score of -0.9 was 0.35 with
a 95% simultaneous confidence interval of (0.27,0.41) and a 95% pointwise
confidence interval of (0.30,0.38). In Figure 1(c)(d), we present their coun-
terparts with respect to cardiovascular disease related death and death from
other causes.
Note that the 5-year rate from “other causes” is rather flat over v. On
the other hand, patients with low risk scores (< −2), the prostate cancer
death rates are low. However, the CV mortality rates are high. Therefore,
for this group of future patients treated by DES high doses, one would closely
monitor the patients’ CV functions. For patients with high risk score (> −2),
it seems that a high dose DES may not be a good choice for treating prostate
cancer.
Now, suppose that we are also interested in predicting a short term com-
peting risk profile. To this end, we let t0 = 2 (years). We fitted the data
12
http://biostats.bepress.com/harvardbiostat/paper100
with a parametric working model (2.2). Here, X = (1, U)′. The estimated
regression coefficients are given in Table 2(b). Note that these estimates ap-
pear to be markedly different from those for the case with t0 = 5 (years),
suggesting that the risk score system may depend on the time point of inter-
est. Using the same setting as that for the above long term competing risk
prediction problem, the resulting smoothing parameter value h is 1.29. The
corresponding profiles for the dependent risks are given in Figure 2. For the
present case, the mortality rates for CV death or “other causes” death are
relatively flat over the entire index score. On the other hand, it appears that
the high dose DES works well for patients whose risk scores are lower than
−2.
5. REMARKS
It is important to note that in this paper the index scoring system is
constructed based on the contrast between the primary event rate and the
average of all other competing risks at a specific time point via (2.2). In
general, it is difficult, if not impossible, to create a univariate scoring system
for grouping the subjects, which is sensitive to differentiating subject-level
risks of all causes. On the other hand, for some specific situations, one
may be able to construct a “sharper” index score. For example, in the DES
study, since we are particularly concerned about the fatal cardiovascular risks
with the high DES dose treatment, for each subject a modified score may
be defined as a contrast of two univariate scores, one is βˆ′X utilized in this
article, and the other one is derived by modeling the CV death rate pi2(U)
via (2.2).
In this paper, we are interested in estimating the competing risks at a
fixed time point (or a set of time points). We find that in general, for a
subject with a covariate vector U , its score index for predicting long term
risks can be quite different from that for short term risks. If a single score
system is needed without a specific set of time points of interest, one may
13
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fit the data with a Cox-type model for the conditional cumulative incidence
function (Fine and Gray, 1999; Cheng et al., 1998), say, for example, of
the time to prostate cancer death in the DES example. The resulting risk
estimates ηˆk(v), k = 1, · · · , K−1, in (2.5) are functions of time t. It would be
interesting to examine the properties of these estimates as processes of t for
a fixed risk index v. Cheng et al. (1998) proposed parametric counterparts
of such estimators, but their estimators are likely biased when the models
are not correctly specified.
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Appendix A: The Asymptotical Properties of
ηˆ(v)
Recalling that βˆ is a solution from the estimating equation
n−1
n∑
i=1
wi
Gˆ(Ti ∧ t0)
Xi{I(Ti ≤ t0,  = 1)− g(β′Xi)} = 0,
it follows from the similar arguments used in Tian et al.(2007) that βˆ con-
verges to a deterministic limit β0 and
βˆ − β0 = n−1ξi + op(n−1)
where β0 is the solution of r(β) = 0,
ξi = [E{g˙(β′0Xi)X⊗2i }]−1
(
Xi{I(T˜i ≤ t0,  = 1)− g(β′Xi)}
−
∫ t0
0
K(Xi{I(T˜i ≤ t0,  = 1)− g(β′Xi)}, u) dM
C
i (u)
G(Ti ∧ t0)
)
,
K(W,u) = W − E{WI(T˜ ∧ t0 ≥ u)}/pr(T˜ ∧ t0 ≥ u) for any random vector
W and MCi (u) is the martingale process associated with the censoring time
Ci. Let Vi = β
′
0Xi and Vˆi = βˆ
′Xi. With slightly abuse of notation, we let
{aˆ(v)′, bˆ(v)′}′ be the maximizer of
n∑
i=1
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)
(
K−1∑
k=1
Yik{ak + bk(Vˆi − v)} − log
[
1 +
K−1∑
k=1
exp{ak + bk(Vˆi − v)}
])
,
and then it is the solution to the estimating equation
Sˆ(a, b; v) = {Sˆ ′1(a, b; v), · · · , Sˆ ′K−1(a, b; v)}′ = 0
where
Sˆk(a, b; v) = n
−1
n∑
i=1
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)
(
1
Vˆi − v
){
Yik − exp{ak + bk(Vˆi − v)}
1 +
∑K−1
k=1 exp{ak + bk(Vˆi − v)}
}
.
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To study the asymptotical properties of aˆ(v), we let ∆ˆa(v) = {aˆ1(v) −
m1(v), · · · , aˆK−1(v)−mK−1(v)}′ and ∆ˆb(v) = h{bˆ1(v)−m˙1(v), · · · , bˆK−1(v)−
m˙K−1(v)}, where mj(v) = log{ηj(v)/ηK(v)} and m˙j(v) = dmj(v)/dv, j =
1, · · · , K − 1. Therefore, {∆ˆa(v)′, ∆ˆb(v)′}′ is the solution to the estimating
equation
Qˆ(∆a,∆b; v) = {Qˆ′1(∆a,∆b; v), · · · , Qˆ′K−1(∆a,∆b; v)}′ = 0
where Qˆk(∆a,∆b; v) is
n−1
n∑
i=1
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)
(
1
(Vˆi − v)/h
){
Yik − e
∆ak+∆bk (Vˆi−v)/h+m¯k(Vˆi,v)
1 +
∑K−1
k=1 e
∆ak+∆bk (Vˆi−v)/h+m¯k(Vˆi,v)
}
∆a = (∆a1 , · · · ,∆aK−1)′, ∆b = (∆b1 , · · · ,∆bK−1)′ and m¯k(u, v) = mk(v) +
m˙k(v)(u− v). Following the similar arguments used in Cai et al. (2008), one
may show that the changes in Qˆk(∆a,∆b; v) by replacing Gˆ(·) and Vˆi by G(·)
and Vi, respectively, are asymptotically negligible. Let Qk(∆a,∆b;h, v) be
n−1
n∑
i=1
wiKh(Vi − v)
G(Ti ∧ t0)
(
1
(Vi − v)/h
){
Yik − e
∆ak+∆bk (Vi−v)/h+m¯k(Vi,v)
1 +
∑K−1
k=1 e
∆ak+∆bk (Vi−v)/h+m¯k(Vi,v)
}
,
and write difference Qˆk(∆a,∆b; v)−Qk(∆a,∆b; v) as
− n−1
n∑
i=1
{Gˆ(Ti ∧ t0)−G(Ti ∧ t0)} wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)G(Ti ∧ t0)
(
1
(Vˆi − v)/h
)
{
Yik − exp{∆ak + ∆bk(Vˆi − v)/h+ m¯k(Vˆi, v)}
1 +
∑K−1
k=1 exp{∆ak + ∆bk(Vˆi − v)/h+ m¯k(Vˆi, v)}
}
+
∫ v+h
v−h
Kh(s− v)
dPn
[
I(s < βˆ′X)
(
1
(βˆ′X − v)/h
){
Yk − e
∆ak+∆bk (βˆ
′X−v)/h+m¯k(βˆ′X,v)
1 +
∑K−1
k=1 e
∆ak+∆bk (βˆ
′X−v)/h+m¯k(βˆ′X,v)
}
−I(s < β′0X)
(
1
(β′0X − v)/h
){
Yk − e
∆ak+∆bk (β
′
0X−v)/h+m¯k(β′0X,v)
1 +
∑K−1
k=1 e
∆ak+∆bk (β
′
0X−v)/h+m¯k(β′0X,v)
} ]
× w
G(T ∧ t0) ,
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which is bounded by
sup
t
|Gˆ(t)−G(t)| × n−1
n∑
i=1
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)G(Ti ∧ t0)
(
1
(Vˆi − v)/h
) {
Yik
− exp{∆ak + ∆bk(Vˆi − v)/h+ m¯k(Vˆi, v)}
1 +
∑K−1
k=1 exp{∆ak + ∆bk(Vˆi − v)/h+ m¯k(Vˆi, v)}
}
+Op(h−1n−1/2)×(
Gn
[
I(s < βˆ′X)
(
1
(βˆ′X − v)/h
){
Yk − e
∆ak+∆bk (βˆ
′X−v)/h+m¯k(βˆ′X,v)
1 +
∑K−1
k=1 e
∆ak+∆bk (βˆ
′X−v)/h+m¯k(βˆ′X,v)
}
−I(s < β′0X)
(
1
(β′0X − v)/h
){
Yk − e
∆ak+∆bk (β
′
0X−v)/h+m¯k(β′0X,v)
1 +
∑K−1
k=1 e
∆ak+∆bk (β
′
0X−v)/h+m¯k(β′0X,v)
} ]
×
w
G(T ∧ t0) +Op(h
2 + n−1/2)
)
= Op{n−1/2 + (nh2)−3/4+δ0 + (nh)−1},
for some small δ0 > 0, where Pn and P are the expectation operator with
respect to the empirical distribution of {(Ti,∆i, i, Ui), i = 1, · · · , n} and
the distribution of (T,∆, , U), respectively, and Gn = n
1/2(Pn − P). Fur-
thermore, since Q(∆a,∆b; v) = {Q1(∆a,∆b; v), · · · , QK−1(∆a,∆b; v)}′ can
be written as sum of n identically distributed independent random func-
tions, it follows from the standard arguments that it uniformly converges to
q(∆a,∆b; v) = {q1(∆a,∆b; v), · · · , qK−1(∆a,∆b; v)}′, where
qk(∆a,∆b; v) =
 g0(v) ∫ K(x)
[
ηk(v)− exp{∆ak+∆bkx+mk(v)}1+∑K−1k=1 exp{∆ak+∆bkx+mk(v)}
]
dx
g0(v)
∫
xK(x)
[
ηk(v)− exp{∆ak+∆bkx+mk(v)}1+∑K−1k=1 exp{∆ak+∆bkx+mk(v)}
]
dx
 ,
and g0(·) is the density function of the random variable β′0X. Since (∆′a,∆′b)′ =
(0′, 0′)′ is the unique solution of q(∆a,∆b; v) = 0. ∆ˆa(v) and ∆ˆb(v) converge
to zero uniformly in v, assuming that the “slope” matrix of q(∆a,∆b; v) is
nonsingular. Coupled with the consistency of ∆ˆa and ∆ˆb, the Taylor series
expansion can be used to show that
∆ˆa(v) = A(u)
−1n−1
n∑
i=1
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)

Yi1 − exp{m¯1(Vˆi,v)}1+∑K−1k=1 exp{m¯k(Vˆi,v)}· · ·
Yi(K−1) − exp{m¯K−1(Vˆi,v)}1+∑K−1k=1 exp{m¯k(Vˆi,v)}
+op{(nh)−1/2},
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where
A(u) = g0(v)

η1(u){1− η1(u)} −η1(u)η2(u) · · · −η1(u)ηK−1(u)
−η2(u)η1(u) η2(u){1− η2(u)} · · · −η2(u)ηK−1(u)
· · · · · · · · · · · ·
−ηK−1(u)η1(u) −ηK−1(u)η2(u) · · · ηK−1(u){1− ηK−1(u)}
 .
Again, following the similar arguments in Cai et al. (2008), one may show
that
n−1
n∑
i=1
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)
{
Yik − exp{m¯k(Vˆi, v)}
1 +
∑K−1
k=1 exp{m¯k(Vˆi, v)}
}
can be approximated by
n−1
n∑
i=1
wiKh(Vi − v)
G(Ti ∧ t0)
{
Yik − exp{m¯k(Vi, v)}
1 +
∑K−1
k=1 exp{m¯k(Vi, v)}
}
uniformly in v up to an order of op{(nh)−1/2} for h = n−ν , ν ∈ (1/5, 1/2).
Noting that the consistent estimator for ηk(v) is
ηˆk(v) =
exp{aˆk(v)}
1 +
∑K−1
j=1 exp{aˆj(v)}
,
by δ−method we have
f{ηˆ1(v)} − f{η1(v)}
f{ηˆ2(v)} − f{η2(v)}
· · ·
f{ηˆK−1(v)} − f{ηK−1(v)}

=D(v)A(u)∆ˆa(v)/g0(v) + op{(nh)−1/2}
=D(v)n−1
n∑
i=1
wiKh(Vi − v)
g0(v)G(Ti ∧ t0)

Yi1 − exp{m¯1(Vi,v)}1+∑K−1k=1 exp{m¯k(Vi,v)}
· · ·
Yi(K−1) − exp{m¯K−1(Vi,v)}1+∑K−1k=1 exp{m¯k(Vi,v)}
+ op{(nh)−1/2},
where D(v) = diag[f˙{η1(v)}, · · · , f˙{ηK−1(v)}] and f˙(·) is the derivative of
f(·). Therefore by the central limit theorem
(nh)1/2[f{ηˆ(v)} − f{η(v)}]→ N{0,Σ(v)},
in distribution as n→∞.
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Appendix B: The Justification of the Resam-
pling Methods
To justify the resampling-based variance estimator, note that the variance
estimator σ˜2k(v) can be approximated by
f˙ 2{ηˆk(v)}
gˆ20(v)
n−1
n∑
i=1
EBi
[
wiKh(V
∗
i − v)
G∗(Ti ∧ t0) {Yik −
eaˆk(v)+bˆk(V
∗
i −v)
1 +
∑K−1
k=1 e
aˆk(v)+bˆk(V
∗
i −v)
}Bi
]2
=
f˙ 2{ηˆk(v)}
gˆ20(v)
n−1
n∑
i=1
[
wiKh(Vˆi − v)
Gˆ(Ti ∧ t0)
{Yik − e
aˆk(v)+bˆk(Vˆi−v)
1 +
∑K−1
k=1 e
aˆk(v)+bˆk(Vˆi−v)
}
]2
+ op(1),
which uniformly converges to σ2k, the asymptotical variance of n
1/2[f{ηˆk(v)}−
f{ηk(v)}], in probability as n → ∞, where EBi is the expectation with re-
spect to the random weights {B1, · · · , Bn}, which are independent of the
observed data. The first approximation follows from the fact that |βˆ∗− βˆ|+
supt |G∗(t) − Gˆ(t)| is in the order of Op(n−1/2) and similar arguments used
to bound the difference between Qˆk(∆a,∆b; v) and Qk(∆a,∆b; v).
To justify the proposed procedure for constructing the simultaneous con-
fidence band of ηk(v), v ∈ I, first note that we have already established that
uniformly in v,
(nh)1/2[f{ηˆk(v)} − f{ηk(v)}]
=(nh)1/2
f˙{ηk(v)}
g0(v)
n−1
n∑
i=1
wiKh(Vi − v)
G(Ti ∧ t0)
{
Yi1 − e
m¯k(Vi,v)
1 +
∑K−1
k=1 e
m¯k(Vi,v)
}
+ op(n−δ0)
=(nh)−1/2
n∑
i=1
K
(
Vi − v
h
)
ξki + op(n−δ0),
for some δ0 > 0, where
ξki =
f˙{ηk(Vi)}wi
g0(Vi)G(Ti ∧ t0){Yik − ηk(Vi)}.
Let
S = sup
I
(nh)1/2|f{ηˆk(v)} − f{ηk(v)}|/σ˜k(v)
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and immediately we have
S = sup
I
∣∣∣∣ 1(nh)1/2σk(v)
n∑
i=1
K
(
Vi − v
h
)
ξki
∣∣∣∣ +op(n−δ0).
From the strong approximation theorem, one may construct a sequence of
standard bivariate Wiener processes Wn(x, y) such that
S = sup
I
∣∣∣∣ 1(nh)1/2σk(v)
∫
K
(
x− v
h
)
ydWn{M(x, y)}
∣∣∣∣ +op(n−δ0)
in an appropriate probability space, where M(x, y) is the Rosenblatt trans-
formation such that M(Vi, ξi) is uniformly distributed on the unit square.
Furthermore, it follows from the similar arguments in Bickel and Rosenblatt
(1973) that
pr({−2 log(h)}1/2(S − dh) ≤ s) = exp(−2e−x) + o(1),
as n→∞, where
dh = {−2 log(h)}1/2 + 1{−2 log(h)}1/2 log
{ ∫
K˙(t)2dt
4pi
∫
K(t)2dt
}
.
Unlike the supremum value of tight processes, S itself does not converge
in distribution, since dh → ∞ as n → ∞. In parallel arguments S∗, the
resampling counterpart of S, is equivalent to
sup
I
∣∣∣∣ 1(nh)1/2σk(v)
n∑
i=1
K
(
Vi − v
h
)
ξˆkiBi
∣∣∣∣ +op(n−δ0)
= sup
I
∣∣∣∣ 1(nh)1/2σk(v)
∫
K
(
x− v
h
)
ydW ∗n{M∗(x, y)}
∣∣∣∣ +op(n−δ0)
for some δ0 > 0 where
ξˆki =
f˙{ηˆk(Vˆi)}wi
gˆ0(Vˆi)Gˆ(Ti ∧ t0)
{Yik − ηˆk(Vˆi)}
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and W ∗n{M∗(x, y)} is a sequence of mean zero Gaussian processes, whose
covariance function is identical to that of Wn{M(x, y)} conditional on the
observed data. Let T ∗ = {−2 log(h)}1/2(S∗−dh) and T = {−2 log(h)}1/2(S−
dh). It follows that
|prB(T ∗ ≤ s)− pr(T ≤ s)| = op(n−δ0),
which implies that we can use the conditional distribution of S∗ to approxi-
mate that of S, where prB is conditional on the observed data.
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Table 1: Coding of the covariates for the prostate cancer data
value
Variable 0 1 2
AG < 75 years 75-79 years ≥ 80 years
WT ≥ 100 80-99 < 80
PF Normal Limited
HX No Yes
HG ≥ 12g/100ml 9-11.9 g/100ml <9 g/100ml
SZ < 30 cm2 ≥ 30 cm2
SG ≥ 10 > 10
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Table 2: Regression Coefficient Estimates for Model (2.2) with the data from
the high dose groups
(a) Time point t0 = 5 years
Coefficient Estimate Std. Error p-value
Intercept -4.64 0.79 < 0.01
AG -0.07 0.31 0.81
WT 0.66 0.37 0.07
PF 0.56 0.61 0.35
HX -0.56 0.46 0.23
HG 0.46 0.42 0.27
SZ 1.76 0.50 < 0.01
SG 3.37 0.75 < 0.01
(b) Time point t0 = 2 years
Coefficient Estimate Std. Error p-value
Intercept -5.87 1.12 < 0.01
AG -0.18 0.39 0.63
WT 0.74 0.40 0.06
PF -0.15 0.69 0.82
HX 0.29 0.54 0.58
HG 1.19 0.45 < 0.01
SZ 1.12 0.55 0.045
SG 3.25 1.05 < 0.01
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(a)
Figure 1: Consistent estimates (solid curve), pointwise 0.95 confidence inter-
vals (enclosed by dotted curves) and simultaneous intervals (gray area) for
various risks ηk(v) at t0 =5 years: (a) The density function for the index
score; (b) Inference for η1(v); (c) inference for η2(v) ; (d) Inference for η3(v).
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Figure 2: Consistent estimates (solid curve), pointwise 0.95 confidence inter-
vals (enclosed by dotted curves) and simultaneous intervals (gray area) for
various risks ηk(v) at t0 =2 years: (a) The density function for the index
score; (b) Inference for η1(v); (c) inference for η2(v) ; (d) Inference for η3(v).
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